Measuring the quality and safety of upper endoscopy in patients taking glucagon-like peptide 1 receptor agonists

Similar Items

• Nephroprotective potential of glucagon-like peptide-1 receptor agonists
  by: Minara S. Shamkhalova, et al.
  Published: (2020-04-01)
• Glucagon-like peptide-1 receptor agonists in patients treated with antipsychotics
  by: A. Delgado, et al.
  Published: (2021-04-01)
• Glucagon-Like Peptide-1 Receptor Agonists for Chronic Weight Management
  by: Magda Wojtara, et al.
  Published: (2023-01-01)
• The potential of glucagon-like peptide-1 receptor agonists in heart failure
  by: Frederik Flindt Kreiner, et al.
  Published: (2022-09-01)
• A Review and Meta-Analysis of the Safety and Efficacy of Using Glucagon-like Peptide-1 Receptor Agonists
  by: En-Hao Hu, et al.
  Published: (2024-02-01)